139 related articles for article (PubMed ID: 21961333)
1. [Current methods of systemic amyloidosis diagnosis and monitoring of its course].
Rameev VV; Kozlovskaia LV; Malinina EA; Serova AG; Kogarko IN; Kogarko BS; Liubimova NV
Ter Arkh; 2011; 83(8):48-54. PubMed ID: 21961333
[TBL] [Abstract][Full Text] [Related]
2. [Serum amyloid A (SAA) 1, SAA 2 and apolipoprotein E isotype frequencies in rheumatoid arthritis patients with AA amyloidosis].
Okuda Y; Yamada T; Takasugi K; Takeda M; Nanba S; Onishi M; Miyamoto T; Inoue Y
Ryumachi; 1999 Feb; 39(1):3-10. PubMed ID: 10332210
[TBL] [Abstract][Full Text] [Related]
3. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
Arthritis Rheum; 2003 Nov; 48(11):3068-76. PubMed ID: 14613268
[TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A in the assessment of early inflammatory arthritis.
Cunnane G; Grehan S; Geoghegan S; McCormack C; Shields D; Whitehead AS; Bresnihan B; Fitzgerald O
J Rheumatol; 2000 Jan; 27(1):58-63. PubMed ID: 10648018
[TBL] [Abstract][Full Text] [Related]
6. [An AA-amyloidosis course in patients with rheumatoid arthritis].
Sarkisova IA; Rameev VV; Varshavskiĭ VA; Golitsyn EP; Kozlovskaia LV
Ter Arkh; 2006; 78(5):31-6. PubMed ID: 16889046
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
Maury CP; Wegelius O
Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
[TBL] [Abstract][Full Text] [Related]
8. Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties.
Bokarewa M; Abrahamson M; Levshin N; Egesten A; Grubb A; Dahlberg L; Tarkowski A
J Rheumatol; 2007 Jun; 34(6):1293-301. PubMed ID: 17552057
[TBL] [Abstract][Full Text] [Related]
9. [New possibilities of the diagnosis and monitoring of the course of AL-amyloidosis].
Rameev VV; Kozlovskaia LV; Kogarko IN; Kogarko BS
Ter Arkh; 2010; 82(6):29-32. PubMed ID: 20731106
[TBL] [Abstract][Full Text] [Related]
10. Raised circulating interleukin-18 levels in reactive AA-amyloidosis.
Maury CP; Tiitinen S; Laiho K; Kaarela K; Liljeström M
Amyloid; 2002 Jun; 9(2):141-4. PubMed ID: 12440487
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-linked immunosorbent assay of serum protein SAA in rhesus monkeys with secondary amyloidosis.
Doepel FM; Glorioso JC; Newcomer CE; Skinner M; Abrams GD
Lab Invest; 1981 Jul; 45(1):7-13. PubMed ID: 7253566
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative analysis of serum amyloid A protein isotypes].
Yamada T
Rinsho Byori; 1990 Feb; 38(2):183-7. PubMed ID: 1691798
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory findings and serum levels of amyloid A and soluble interleukin-2 receptors in patients with renal amyloidosis].
Rysavá R; Merta M; Tesar V; Zabka J; Spicka I; Stejskalová A; Vernerová Z
Cas Lek Cesk; 1998 Feb; 137(4):107-9. PubMed ID: 9531732
[TBL] [Abstract][Full Text] [Related]
14. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
[TBL] [Abstract][Full Text] [Related]
15. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Saeki T; Nakano M; Narita I
J Rheumatol; 2012 Jul; 39(7):1348-54. PubMed ID: 22589255
[TBL] [Abstract][Full Text] [Related]
16. Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio.
Kokubun M; Imafuku Y; Okada M; Ohguchi Y; Ashikawa T; Yamada T; Yoshida H
Clin Chim Acta; 2005 Oct; 360(1-2):97-102. PubMed ID: 15932751
[TBL] [Abstract][Full Text] [Related]
17. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S; Shono M
Rheumatology (Oxford); 2006 Jan; 45(1):43-9. PubMed ID: 16219644
[TBL] [Abstract][Full Text] [Related]
18. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
[TBL] [Abstract][Full Text] [Related]
20. Fatal pancreatitis associated with systemic amyloidosis in a rheumatoid arthritis patient.
Oishi K; Wada J; Nagake Y; Hida K; Hashimoto H; Hayakawa N; Kashihara N; Makino H
J Med; 2000; 31(5-6):303-10. PubMed ID: 11508323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
